Bipolar Disorders: Mixed States, Rapid-Cycling, and Atypical Forms

367 Use of atypical antipsychotic agentsKapur, S., and Seeman, P. (2001). Does fast dissociation from dopamine d(2) receptors explainthe action of atypical antipsychotics? A new hypothesis. Am. J. Psychiatry, 158, 360–9.Keck, P. E., Jr., Versiani, M., Ptkin, S. et al. (2003a). Ziprasidone in the treatment of acute bipolarmania. A 3-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry,160, 741–8.Keck, P. E., Jr., Marcus, R., Tourkodimitris, S., et al. (2003b). Aripiprazole versus placebo inacute mania. Am. J. Psychiatry, 160, 1651–8.Khanna, R., Das, A., and Damodaran, S. S. (1992). Prospective study of neuroleptic-induceddystonia in mania and schizophrenia. Am. J. Psychiatry, 149, 511–13.Koukopoulos, A., Reginaldi, D., Laddomada, P., et al. (1980). Course of the manic depressivecycle and changes caused by treatment. Pharmacopsychiatria, 13, 156–67.Krakowski, M., Czobor, P., and Volavka, J. (1997). Effect of neuroleptic treatment on depressivesymptoms in acute schizophrenic episodes. Psychiatry Res., 71, 19–26.Morgan, H. G. (1972). The incidence of depressive symptoms during recovery from hypomania.Br. J. Psychiatry, 120, 537–9.Nasrallah, H. A., Churchill, C. M., and Hamdan-Allan, G. A. (1988). Higher frequency ofneuroleptic-induced dystonia in mania than in schizophrenia. Am. J. Psychiatry, 145, 1455–6.Sachs, G. S., Printz, D. J., Kahn, D. A., Carpenter, D., and Docherty, J. P. (2000). TheExpert Consensus Guideline Series. Medication treatment of bipolar disorder. Postgrad.Med., April, 1–104.Sachs, G., Grossman, F., Ghaemi, N., Okamoto, A., and Bowden, C. (2002a). Combination of amood stabilizer with risperidone or haloperidol for the treatment of acute mania: a doubleblindplacebo controlled comparison of efficacy and safety. Am. J. Psychiatry, 159, 1146–54.Sachs, G., Grossman, F., Ghaemi, S. N., Okamoto, A., and Bowden, C. L. (2002b). Combinationof a mood stabilizer with risperidone or haloperidol for treatement of acute mania: a doubleblind,placebo-controlled comparison of efficacy and safety. Am. J. Psychiatry, 159, 1146–54.Sachs, G., Chengappa, K. N., Suppes, T. et al. (2004). Quetiapine with lithium or divalproex forthe treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.Bipolar Disord., 6, 213–23.Seeman, P. and Trallerico, T. (1999). Rapid release of antipsychotic drugs from dopamine2 receptors: an explanation for low receptor occupancy and early clinical relapse uponwithdrawal of clozapine or quetiapine. Am. J. Psychiatry, 156, 876–84.Segal, J., Berk, M., and Brook, S. (1998). Risperidone compared with both lithium and haloperidolin mania: a double-blind randomized controlled trial. Clin. Neuropharmacol., 121, 176–80.Stanniland, C. and Taylor, D. (2000). Tolerability of atypical antipsychotics. Drug Safety,22, 195–214.Suppes, T., Webb, A., Paul, B., et al. (1999). Clinical outcome in a randomized 1-year trial ofclozapine versus treatment as usual for patients with treatment-resistant illness and a historyof mania. Am. J. Psychiatry, 156, 1164–9.Swann, A. C., Bowden, C. L., Morris, D., et al. (1997). Depression during mania: treatmentresponse to lithium or divalproex. Arch. Gen. Psychiatry, 54, 37–42.Tohen, M. and Zarate, C. Jr. (1998). Antipsychotic agents and bipolar disorder. J. Clin.Psychiatry, 59 (suppl. 1), 38–48.